Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-24Clinical Trial Update: Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa Pharmacokinetics [Phase 1]
A Phase 1 trial evaluated the effect of three multiple-dose regimens of BIA 9 1067 at steady-state on levodopa pharmacokinetics in Parkinson…
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of Warfarin [Phase 1]
Phase 1 study evaluating the effect of BIA 9-1067 on the pharmacokinetics and pharmacodynamics of warfarin in Parkinson's disease patients.
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa [Phase 1]
Phase 1 pharmacokinetic study assessing interaction between the investigational drug BIA 9-1067 and standard-release levodopa/carbidopa in p…
-
FDA approval · 2015-12-21FDA Approved: DUOPA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for DUOPA (carbidopa and levodopa) submitted by AbbVie.
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients [Phase 4]
A Phase 4 trial comparing Rotigotine to placebo to evaluate its effect on depressive symptoms in patients with Parkinson's disease; the stud…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Dexmedetomidine vs Propofol on the Recordings of Deep Brain Activity Measured Through Implanted Stimulators [Phase 4]
This phase 4 trial compares dexmedetomidine versus propofol during recordings from implanted deep brain stimulators in Parkinson's disease t…
-
CLINICAL_TRIALS research · 2015-12-18Clinical Trial Update: Perceptual Decision Making Under Conditions of Visual Uncertainty [NA]
University of California, Los Angeles reports a clinical trial update examining perceptual decision making under visual uncertainty in peopl…
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy [Phase 4]
A completed Phase 4 double-blind, placebo-controlled trial evaluating the effects of rasagiline on cognition in Parkinson's disease patients…
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: Nilotinib in Cognitively Impaired Parkinson Disease Patients 001 [Phase 1]
Phase 1 trial update evaluating nilotinib in cognitively impaired Parkinson's disease patients has completed.
-
FDA approval · 2015-12-14FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Carbidopa and Levodopa from Zydus Pharmaceuticals USA Inc.
-
FDA approval · 2015-12-11FDA Approved: ROPINIROLE HYDROCHLORIDE — Supplemental Application (SOLCO HEALTHCARE US, LLC)
FDA approved a supplemental application for ropinirole hydrochloride from Solco Healthcare US, LLC.
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: Study of the Safety and Efficacy of Tropicamide Thin Films to Reduce Hypersalivation in Parkinson's Patients [Phase 2]
Phase 2 study evaluating tropicamide thin films to reduce hypersalivation in Parkinson's disease has completed, assessing safety and efficac…
-
FDA approval · 2015-12-09FDA Approved: AZILECT — Supplemental Application (Teva Neuroscience, Inc.)
The FDA approved a supplemental application for AZILECT (rasagiline mesylate) submitted by Teva Neuroscience, Inc.
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: PD4PD:Partnered Dance for Parkinson Disease [Phase 2, Phase 3]
Clinical trial update for the PD4PD partnered dance program in Parkinson disease, spanning Phase 2 and Phase 3, sponsored by Washington Univ…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease [Phase 4]
Phase 4 trial assessing fixed-dose ropinirole prolonged-release as adjunctive therapy in advanced Parkinson's disease; results have been pos…
-
FDA approval · 2015-12-02FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for pramipexole dihydrochloride from Macleods Pharmaceuticals Limited under ANDA 202164.
-
CLINICAL_TRIALS research · 2015-11-30Clinical Trial Update: Web-based International Multi-Center Clinical Study for Parkinson's Disease [NA]
An international, web-based multi-center clinical study for Parkinson's disease is being conducted by Seoul National University Hospital; th…
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: DBS Under General Anesthesia: Comparison To The Standard Technique
This clinical trial compares deep brain stimulation under general anesthesia to the standard awake technique in Parkinson's disease. The stu…
-
CLINICAL_TRIALS withdrawal · 2015-11-24Clinical Trial Update: Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study [Phase 2]
Phase 2 open-label safety extension trial of a gastric-retentive formulation of carbidopa/levodopa for Parkinson's disease has been withdraw…
-
FDA approval · 2015-11-19FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic carbidopa/levodopa product from Mylan Pharmaceuticals Inc. for the treatment of Parkin…
-
FDA approval · 2015-11-18FDA Approved: ROPINIROLE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA has approved a supplemental application for ropinirole filed by Alembic Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: Effect of Paracetamol on Opicapone Pharmacokinetics in Healthy Volunteers [Phase 1]
Phase 1 study evaluating whether paracetamol affects the pharmacokinetics of opicapone in healthy volunteers, which could influence dosing c…
-
FDA approval · 2015-11-17FDA Approved: ROPINIROLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's supplemental application for ropinirole (ropinirole) in the United States. This action approves a supplemental NDA s…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Relative Bioavailability and Bioequivalence Of Different Formulations of Opicapone in Healthy Volunteers [Phase 1]
Phase 1 study evaluating relative bioavailability and bioequivalence of different formulations of opicapone in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2015-11-16Clinical Trial Update: Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of Levodopa/Carbidopa and Levodopa/Benserazide [Phase 1]
A Phase 1 study evaluating how steady-state BIA 9-1067 affects the pharmacokinetics of Levodopa/Carbidopa and Levodopa/Benserazide in Parkin…